TrendBio and Basepair Inc. Announce Distribution Agreement to Boost Genomic Research

TrendBio and Basepair Inc. have formed a distribution agreement to advance genomic research in Australia and New Zealand. This collaboration aims to enhance access to cutting-edge genomic tools and technologies in the region.

NEW YORK, NY, UNITED STATES, February 12, 2025 /ennovaterz/ — Basepair Inc., a pioneer in point-and-click bioinformatics, announced today that it has forged a strategic partnership with TrendBio, a leading supplier of medical research instruments and consumables in Australia and New Zealand. This collaboration will introduce Basepair’s innovative federated analysis and interactive visualization platform for next-generation sequencing (NGS) data to researchers across Australia and New Zealand, leveraging TrendBio’s established presence in the region.

This agreement marks a significant step in expanding Basepair’s presence in the Australasian market, enabling TrendBio to offer a comprehensive suite of genomic analysis tools, including capabilities for DNA, RNA, epigenetics, and multi-omics. By integrating Basepair’s user-friendly platform into its existing portfolio, TrendBio will enhance its service offerings from experimental design to data interpretation.

“Basepair’s platform represents a breakthrough in simplifying NGS data analysis while addressing crucial data security concerns,” said Trent Warburton, CEO of TrendBio. “Their innovative hybrid architecture allows data to remain within Australia and New Zealand, complying with local data residency laws. With our strong network in the Australasian scientific community and commitment to supporting researchers, we believe this partnership will facilitate greater access to advanced genomic technologies, accelerate scientific discoveries, and ensure data sovereignty.”

Simon Valentine, Chief Commercial Officer of Basepair Inc., expressed enthusiasm about the collaboration: “Our goal is to empower scientists by providing them with intuitive tools for analysis and visualization without the need for data to leave the country of origin. Partnering with TrendBio allows us to reach a broader audience in Australia and New Zealand and support researchers in overcoming the complexities associated with NGS technologies.”

TrendBio is well-positioned to support this initiative due to its extensive experience in the life sciences sector and its established relationships with various research institutions across Australia and New Zealand. This partnership aligns with TrendBio’s mission to deliver cutting-edge solutions that enhance research capabilities and drive innovation within the scientific community.